Quantcast

Latest Plasmodium vivax Stories

2010-08-04 15:08:29

A new evidence-based global distribution map of Plasmodium vivax malaria, published August 3 in the open-access journal PLoS Neglected Tropical Diseases, is used to estimate that 2.85 billion people lived at risk of infection with this parasite in 2009. The map, created as part of the Malaria Atlas Project (MAP), a multinational research collaboration funded mainly by the Wellcome Trust, reviews a host of information that challenges the dogma that P. vivax transmission is absent through large...

2010-04-18 23:01:00

ROCKVILLE, Md., April 19 /PRNewswire/ -- Protein Potential LLC has received support from the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH in the form of a Phase II Small Business Innovation Research (SBIR) Grant. The three-year award totaling approximately $3 million will support translational research to develop a vaccine for the prevention of malaria caused by the parasite Plasmodium vivax. Approximately 40% of the world's population is at risk from malaria...

2010-03-15 15:45:00

Study proves blood-stage infection due to population mixing and disease evolution In a paradigm changing discovery, Plasmodium vivax (P. vivax) malaria has been identified in a population historically thought to be resistant to the disease, those who do not express the Duffy blood group protein on their red blood cells, according to researchers from Case Western Reserve University School of Medicine, Pasteur Institute, and the Madagascar Ministry of Health. In a study of more than 600...

2008-10-09 18:00:37

A U.S.-led team of scientists has identified the complete genetic sequence of a parasite that is the leading cause of relapsing malaria. Working at The Institute for Genomic Research/J. Craig Venter Institute in Rockville, Md., the scientists studied the parasite Plasmodium vivax. Unlike three other species of Plasmodium that cause malaria, the researchers said P. vivax cannot be grown in the laboratory, severely limiting its scientific study. "Completion of the P. vivax genome promises to...

2008-08-26 03:00:17

By Cooper, R G Magwere, T Chloroquine (CHQ) is a cheap, relatively well tolerated drug initially developed for the treatment of malaria in the 1930s. CHQ has, however, since accrued a plethora of uses in the treatment and amelioration of several other diseases and conditions because of its lysosomotropic properties. It also has characteristic physiological and systemic effects. This review gives an overview of the history and pharmacology of CHQ, and progresses to consider some of the...

2005-09-22 14:45:31

By specially tagging the outer and inner membranes of red blood cells infected with the malaria parasite and tracking the cellular changes that precede the cell bursting event that disperses parasites to other blood cells, a group of researchers has deepened our understanding of how the malaria pathogen destroys the cells in which it resides. The work is reported in Current Biology by Joshua Zimmerberg and colleagues at the U.S. National Institutes of Health. Malaria devastates humanity:...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.